Population
Hypertensive patients
Design
Review
Authors
Loading...
Highlights evolving options for initial hypertension therapy; leaves open the place of newer agents and low-dose combinations in practice.
This symposium introduction outlines discussions on the optimal initial pharmacological management of hypertension, including the role of newer agents and low-dose fixed combinations.
M. Moser (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: